6:07pm: Trout isn’t likely to be sidelined for more than a few days, but may require further offseason medical care to address the foot issue, per skipper Brad Ausmus (via Jeff Fletcher of the Southern California News Group, on Twitter). There’s no concern that playing out the year will cause greater harm.
5:52pm: Angels superstar Mike Trout has undergone a cryoablation procedure on his right foot to “address a neuroma,” per a club announcement. He’s considered day-to-day.
In plain English, the procedure froze some nerve tissue that had been causing pain in or around Trout’s right toe. It is not entirely clear at this point how long the center fielder will be sidelined, but it seems that his own pain tolerance will largely dictate the recovery schedule.
All indications are that this non-invasive approach will not be much of a short or long-term limitation on the game’s greatest player. Medical literature suggests it can take a full month for such a procedure to be fully effective, but that full resumption of activity is possible within a few days.
The Halos will surely exercise caution, lest their franchise icon somehow come down with a more significant malady. Barring a surprise development, the procedure shouldn’t even ding Trout’s chances at securing an American League MVP award. (It’s no surprise that he’s easily pacing all of baseball with 8.7 fWAR to this point.)